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Recent Progress in Safety Evaluation Studies
on Plasticizers and PlasticsandTheirControlled
Use in Japan
by Yoshihito Omori*
Recent experimental studies in Japan on the evaluation of potential health hazards
from phthalate esters used in manufacturing poly(vinyl chloride) as well as several
plastics for medical devices and for food containers and packages were introduced. Devel-
opment of pulmonary granuloma formation after intravenous iniection of diethylhexyl
phthalate was assumed to be dependent on the particle size of the phthalate in vehicle
used. Dietary administration of large amount of diethylhexyl phthalate and dibutyl
phthalate produced renal cysts in mothers and in descendants in reproduction studies in
mice. Cytotoxicity and mutagenicity of the phthalates and several plastics and resins
were also examined by in vivo and in vitro studies. Hematological parameters examined
in rabbits after repeated intravenous injection of diethylhexyl phthalate and after im-
plantation of plastics in aorta for 3-6 months did not show any significant change. A
slow decrease of radioactivity was observed in adipose tissue of rats following oral
administration of 14C-labeled diethylhexyl phthalate. The administrative action on phthal-
ates by the Japanese Ministry of Health and Welfare is briefly reviewed.
Plastics have found wide usage in medical
and paramedical applications as well as for
food containers and wrapping materials. In the
past much attention was directed at the physi-
cal, chemical, and mechanical properties of
these materials in meeting the requirements
for developing suitable products. However,
more recently, attention has been focused on
the potential toxic liability of these products
when they are used for medical purposes or as
contaminants of the food or materials which
may come into contact with the human body.
Since Jaeger and Rubin (1) pointed out that
diethylhexyl phthalate (DEHP) accumulated
in rat liver after perfusion and in the human
spleen and abdominal adipose tissue after blood
transfusion, evaluation of the safety of phtha-
lates used as additives in manufacturing poly-
vinyl chloride products became a matter of
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concern and interest in Japan. The Ministry of
Health and Welfare and many institutes began
to examine the effects of plasticizers on blood,
their accumulation in tissues, and their other
toxicological effects in experimental animals.
Of the many plasticizers, DEPH has been
mainly used for these studies.
Acute Toxicity Studies
Miyahara et al. (2) administered DEHP
and dibutyl phthalate (DBP) to male adult
mice orally and by intravenous injection. The
mice treated orally tolerated 100 g/kg of
DEHP, and the LD50 of DBP was 9.77 g/kg
on day 7 of observation; for those treated in-
travenously the LD50 values were 1.37 g/kg
and 0.72 g/kg, respectively. Yamada (3) ad-
ministered DEHP orally to male and female
mice at doses of 22.7, 69.4 ml/kg, and the
LD50 after 7 days was 49.7 ml/kg; toxic symp-
toms including decrease of spontaneous move-
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Administration
Samples Sex route Term, days LDw0, g/kg Reference
DEHP M PO 7 >100 Miyahara (2)
DEHP M,F PO 7 49.7 (48.3-51.1) Yamada (3)
DEHP M PO 7 > 150 Suzuki (4)
F PO 7 > 150 Suzuki (4)
DEHP M IV 7 1.37 (1.22-1.55) Miyahara (2)
DBP M PO 7 15.9 (14.8-17.0) Yamada (6)
ments, decrease of body temperature, and loss
of body hair were observed.
Oba and Suzuki (4) also administered
DEHP orally to male and female mice and re-
ported that both sexes tolerated 150 g/kg dose.
Miyahara (2) intravenously injected 0.5
ml/kg of undiluted DEHP to a dog and found
necrosis with embolism in the lung tissue after
6 days. He found granuloma with perivascular
histocyte infiltration in the lung of rats 30 days
after a single intravenous injection of 0.1 ml/
kg of DEHP. Miyahara assumed that these
pathological changes may be due to the toxicity
of the materials rather than their physical
properties.
Oba and et al. (5) injected rats intraaven-
ously with undiluted DEHP and emulsified
DEHP which was sonicated in rat serum to an
average particle size of less than 2 Mm. The
dose given was 5, 10, and 50 ul/kg in the ani-
mals given undiluted DEPH and 50 ug/kg in
the group receiving emulsified serum. Five ani-
mals in each group were sacrificed on days 1,
3, 6, 15 and 30 after the injection. In the
groups of animals receiving undiluted DEHP
the dose-dependent accumulation of droplets in-
creased in the capillaries of alveolar wall with
polymorphnuclear cell infiltration on day 1.
These lesions developed to granuloma with a
proliferation of histocytes and fibroblasts by
day 3. After 15 days these lesions were found
to have decreased. These findings were assumed
to be nonspecific granuloma formation due to
the injection of oily foreign materials. In the
group injected with the DEHP emulsion serum,
similar but less severe changes were observed.
Autoradiographic examination of male rats 6
hr after 14C-DEHP injection with and without
dilution of the serum, accumulation of radio-
activity in the lungs was observed in the group
receiving undiluted sample but not in the group
receiving serum-emulsified DEHP. These find-
ings were considered to support the histopatho-
logical findings.
Subacute and Chronic Toxicity
Yamada (6) fed male rats for 3 months on
a diet containing 0.2, 1, and 5% DEHP. A
weight increase of the liver was observed in
all treated groups, and an increase of drug-
metabolizing enzyme activities of liver micro-
somes was noticed in the two lower dose
groups. In the 5% group, atrophy of the tests
was noted. In another experiment, Yamada
(3) orally administered 1, 4, and 10 ml/kg
DEHP to male and female rats (nine to ten
animals in each group) for 3 weeks. In the 4
ml/kg group the increase in body weight was
small while that in the liver weight was large,
but it was noticed that liver weight returned to
normal levels within 2 weeks after termination
of the treatment. In the 10 ml/kg group, there
was a great increase in the mortality rate and
in the liver weight, with a proliferation of the
bile duct and swelling of Kupffer's cells.
Ohta et al. (7) fed mice a diet including
0.25 and 2.5%o DEHP for three months and
found an increase in the weight of the kidneys
along with formation of renal cysts. Also Ya-
mada (8) fed groups of three to five male rats
with a diet including 0.5% and 2.5%o DEHP
for 21 weeks and found that the weight gain
was at a much lower rate. Both groups showed
an enlargement of the liver, elevation of serum
alkaline phosphatase activity, and cloudy swell-
ing and necrosis of the liver cells and the renal
tublule epithelial cells as well as an absence of
spermatogenesis. Another study of chronic
toxicity of DEHP and DBP is in progress at
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Supply of the National Institute of Hygienic
Sciences.
Teratological and Reproduction Studies
Nakayama et al. (9) administered 2.5 and
5 ml/kg of DEHP orally to rats between days
7 and 13 of pregnancy. The mortality of the
fetuses increased, and about 50% of the im-
plants were resorbed in 2.5 ml/kg group, but
no teratogenic effect was found. Onda et al
(10) examined the effect of DEHP and DBP
administration on two strains (ddY and ICR)
of mice for three generations. Dietary adminis-
tration of these esters at a level of 10 and 100
mg/kg-day increased the formation of renal
cysts in the F1 and F2 generations. The occur-
rence of kidney damage in the offspring of the
group of mothers fed DEHP was found to be
higher than in those the DBP groups and F2
groups of ddY/JCL strain. It was assumed that
these phthalate esters diffused across the pla-
cental barrier and caused the renal damage to
the fetuses.
Cytotoxicity and Mutagenicity Studies
Odashima and Ishidate (11) examined the
inhibition of cell colony formation and inci-
dence of chromosmal aberrations induced by
phthalate esters with cultured Chinese hamster
cells. DEHP inhibited 50% of the colony for-
mation with 0.125 mg/ml. The toxic effect
ranged in the order: DBP, DEHP, DPBG
(butyl phthalyl butylglycolate) and DEP (di-
ethyl phthalate), with DBP having the greatest
effect and DEP the least. Chromosomal aberra-
tion was not produced with 0.5 mg/ml of DEP
and 0.16 mg/ml of DEHP. DEHP also did not
induce any chromosomal change in the ratas-
cites hepatoma cells (AH-13) and in the bone
marrow cells of female rats (AC1/N) after
intraperitoneal injection of 0.2-2 g/kg.
Saito and Itagaki (12, 13) examined the in-
hibition of colony formation of cultured KB
cells derived from human nasopharyngeal car-
cinoma. Silicon, polyethyene, polypropylene,
polystyrene, polycarbonate, and acrylic resins
did not inhibit the KB cell colony formation,
but melamine and urea resins, especially flex-
ible PVC, inhibited colony formation. With the
plasticizers, concentration of 50%7 inhibition
was 36.9 ug/ml with DEP and 10 fAg/ml with
DEHP, respectively.
Kasuya (14) examined the inhibition of the
outgrowth of the cerebellar tissue cells of new-
born rats by tissue culture method. DNBP (di-
n-butyl phthalate) markedly inhibited the cell
Table 2. Incidence of chromosomal aberration induced by phthalate esters in cultured Chinese hamster cells.
Dose, No. cells Chromosomal aberration, % b
Compound mg/ml observed 6 hr 24 hr 48 hr Judgement
0.125 100 _ 1.0(g) 0.0 (-)
DEP 0.250 100 - 1.0(g) 0.0 (-)
0.500 (D) (D) (D) (D)
0.0157 100 1.0(g) 0.0 (-)
DBP 0.0313 200d 3.5(g) 1.5(g,b) (+)
0.0625 200 - 2.0(g) 0.0 (-)
0.040 100 1.0(g) 0.0 0.0 (-)
DEHP 0.080 100 0.0 0.0 0.0 (-)
0.160 100 0.0 0.0 0.0 (-)
0.062 200 - 2.5(g,b) 2.5(g) (-)
BPBG 0.125 200 - 4.5(g) 3.5;(g) (±)
0.250 (D) (D) (D) (D)
Control Saline 300 0.7 0.3 (-)
Albumin 400 1.0 1.2 (-)
a Data of Odashima and Ishidate (11).
b (g) = chromatid gap; (b) = chromatid break; (D) = cell death or no mitosis.
2 Significantly positive: more than 5.0%.
d 100 for each of two experiments.
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Repair test Mutation test
B. subtilis E. coli E. coli S. typhimurium
(uvrA-)
Concentration, (PolA-) (wild ) (TA100 + S9)
Chemicals mg/plate (recA-) (recA-) (uvrA-) (TA98 + S9)
Diethyl phthalate 10
Di-n-butyl phthalate 10
Dihexyl phthalate 30 - -
Diheptyl phthalate 10 - - -
Di-n-octyl phthalate 30
Diisoheptyl-isononyl phthalate 30
Di-n-octyl-n-decyl phthalate 30
Di-isodecyl phthalate 10
Butyl benzyl phthalate 30
Dicyclohexyl phthalate 30
Ethyl phthalyl ethylglycolate 30
Butyl phthalyl butylglycolate 30
Phthalic acid 10
4-Nitroquinoline-l-oxide 0.01 + + +
N-Methyl-N'-nitro-N-nitrosoguanidine 0.1 + + +
a Data of Kuarata (15).
outgrowth at about 11.7 X 10-4M. The inhibi- amined by Kurata (15) on B. subtilis and E.
tions by DBP and DEHP were lower than that coli. Application of 10 mg and 100 mg/plate,
of DNBP. (about 0.3 and 3 mg/ml) of these esters did
Mutagenicity of the twelve samples of phtha- not produce any bacteriocidal or mutagenic ef-
late esters including DBP and DEP was ex- fects, as shown in Table 3.
Table 4. Blood coagulation of rabbits given di(2-ethylhexyl) phthalate intravenously twice weekly for 98 days.a
Dose, Plasma recalcification Prothrombin Thrombelastogram values
mg/kg Day time, sec time, sec r,min k, min r+k, min Max, mm
0 0 136.4 + 12.7 9.0 ± 0.3 12.6 + 1.0 5.1 ± 0.1 17.7 ± 1.0 58.2 ± 2.6
7 132.2 ± 7.7 9.0 ± 0.3 12.8 ± 0.6 4.8 ± 0.3 17.6 ± 0.5 62.6 ± 2.6
14 124.4 ± 5.3 9.3 ± 0.2 14.9 ± 1.1 4.3 ± 0.5 19.2 ± 1.2 59.6 ± 2.4
28 116.3 ± 8.5 9.0 ± 0.4 13.5 ± 1.2 4.7 ± 0.5 18.2 ± 1.4 59.8 + 2.3
56 130.3 ±10.9 9.1 ±0.4 12.1 +0.6 4.3 ± 0.2 16.4 ±0.6 61.8 2.7
98 121.3 ± 2.4 9.7 ± 0.2 13.8 ± 0.6 4.4 ± 0.3 18.2 ± 0.9 59.0 ± 2.1
50 0 127.4 ± 5.0 9.0 ± 0.3 12.4 ± 0.9 4.8 ± 0.5 17.2 ± 1.3 60.2 ± 3.0
7 127.6 ±4.6 9.1 ±0.2 12.3+ 1.0 5.0 0.7 17.3 ± 1.4 57.3 ± 1.7
14 119.3 ±4.4 8.9 ±0.2 14.2 ±0.7 4.1 ± 0.4 18.3 ± 1.0 59.4 ± 3.0
28 128.6 ± 13.9 8.7 ± 0.2 11.1 ± 1.1 5.6 ± 0.4 16.8 ± 1.4 57.3 ± 0.8
56 114.6 ± 1.1 9.2 ± 0.1 13.7 ± 1.4 4.5 ± 0.9 18.2 ± 1.7 57.7 ± 0.3
98 134.6 ± 4.4 9.3 ± 0.5 12.7 ± 0.4 4.7 ± 0.4 17.4 ± 0.4 58.0 ± 1.7
100 0 129.8 ± 5.5 9.2 ± 0.2 14.4 ± 0.6 4.6 ± 0.4 19.0 ± 0.9 58.0 ± 2.5
7 124.8 ± 3.6 8.7 ± 0.3 14.3 ± 1.6 4.5 ± 1.6 18.8 ± 2.3 59.0 ± 4.9
14 124.2 ± 6.5 9.1 ± 0.3 15.3 ± 1.0 4.6 ± 0.3 19.9 ± 0.9 58.0 ± 1.5
28 128.5 8.5 8.8 +0.3 13.1 ±0.6 5.6 ±0.5 18.7 ± 0.5 57.8 1.2
56 129.6 ± 8.2 9.1 ± 0.2 12.6 ± 1.2 4.9 ± 1.0 17.5 ± 1.9 59.2 ± 1.7
98 131.4 2.3 9.3 ±0.2 13.3 ±1.1 5.0 0.3 18.3 ± 1.1 60.7 1.8
a Values give mean and standard error from 5 rabbits. Data of Nakaura et al. (17).
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administration of [T'C]DEHP (1.03 uCi).a
after the intravenous
Radioactivity, %
Organs 1 hr 2 hr 3 hr 6 hr 12 hr 24 hr 7 days
Brain 0.02 + 0.00 0.02 + 0.01 0.02 + 0.01 0.02 + 0.00 0.03 + 0.01 0.01 + 0.00 0.01 + 0.00
(0.020) (0.026) (0.031) (0.028) (0.034) (0.012) (0.006)
Heart 0.19 + 0.04 0.17 + 0.02 0.13 ± 0.01 0.13 + 0.03 0.06 + 0.00 0.02 + 0.01 0.01 + 0.00
(0.54) (0.45) (0.38) (0.33) (0.18) (0.06) (0.015)
Lung 0.30 + 0.07 0.57 + 0.09 0.37 ± 0.08 0.32 + 0.04 0.11 + 0.06 0.04 + 0.02 0.03 + 0.01
(1.32) (0.76) (0.64) (0.47) (0.23) (0.07) (0.045)
Liver 76.16 + 3.73 61.28 + 9.26 51.17 + 2.19 34.12 + 0.73 25.06 + 17.08 5.60 + 5.29 0.17 + 0.04
(14.81) (12.39) (10.39) (7.25) (5.59) (1.53) (0.04)
Spleen 3.02 + 0.91 1.13 ± 0.09 0.44 + 0.15 0.21 + 0.01 1.12 + 0.66 0.08 + 0.11 0.11 + 0.00
(5.70) (2.08) (0.63) (0.40) (3.81) (0.40) (0.015)
Kidney 0.71 + 0.07 0.43 + 0.09 0.43 ± 0.11 0.40 + 0.04 0.13 +. 0.05 0.09 ± 0.05 0.03 + 0.00
(0.83) (0.48) (0.54) (0.43) (0.18) (0.12) (0.03)
Stomach 0.09 + 0.02 0.09 + 0.01 0.08 + 0.01 0.14 + 0.08 0.08 + 0.04 0.04 + 0.04 0.01 + 0.00
(0.15) (0.16) (0.13) (0.25) (0.14) (0.07) (0.015)
Intestine b 18.23 + 2.08 24.42 + 6.22 30.33 + 0.39 28.22 + 3.23 15.84 +. 9.83 12.20 + 14.57 0.15 + 0.17
(2.17) (3.03) (3.66) (3.72) (1.74) (1.92) (0.022)
Testicle 0.04 ± 0.01 0.03 + 0.00 0.03 + 0.00 0.04 + 0.00 0.03 + 0.01 0.01 ± 0.00 0.01 + 0.00
(0.035) (0.030) (0.028) (0.036) (0.026) (0.011) (0.005)
Blood c 2.17 + 1.83 1.27 + 0.52 1.44 + 0.36 1.17 + 0.53 0.68 + 0.35 0.65 + 0.45 0.16 + 0.03
(0.28) (0.16) (0.19) (0.15) (0.09) (0.08) (0.02)
Muscle d 4.78 + 0.41 5.15 + 1.14 5.02 + 0.86 6.20 + 1.98 2.57 + 0.67 2.01 + 0.17 0.76 + 0.25
(0.12) (0.13) (0.13) (0.15) (0.07) (0.22) (0.015)
Adipose tissue e 3.46 ± 1.61 2.88 + 0.11 1.24 ± 0.90 1.79 + 1.70 3.01 + 1.90 2.54 + 0.11 2.08 + 0.11
(0.25) (0.20) (0.09) (0.10) (0.21) (0.18) (0.15)
a Means + S.D.; numbers in parentheses indicate RSA.
RSA = [activity in the organ (dpm)]/[organ weight (g)]
[total dose (dpm)]/ [body weight (g)]
Data of Tanaka et al. (20).
b Intestine includes contents.
c Assumes 7.69% of the body weight to be blood.
d Assumes 40% of the body weight to be muscle.
e Assumes 14% of the body weight to be adipose tissue.
Pharmacological Studies
Sasagawa (16) examined the hemolysis of
human erythrocyte during the storage of
plasma in PVC bags kept at 40C for 6 and 14
days and reported the rate of hemolysis after
storage in plastic bags was lower than that
observed in plasma kept in glass bottles. Miya-
hara et al. (2) injected undiluted 0.5 ml/kg
of DEHP and 0.25 ml/kg of DBP intravenously
into dogs and observed an increase of RBC
counts and hematocrit values within 2 hr and
in WBC counts after 4 hr. The elevations of
serum LDH in both groups and, GOT and ALP
in the DBP group were also observed. A de-
crease of arterial blood pressure, heart rate
and a depression of respiration were noticed.
An intraarterial injection of 0.5 ml of DBP de-
pressed the perfusion pressure in hind leg
preparation.
Nakaura et al. (17) injected male rabbits
intravenously with DEHP emulsified with 5%o
Tween 80 in saline. The particle size of the
sample was less than 25 em. Hematological
parameters such as RBC, WBC, platelets, PCV,
October 1976 207Table 6. Distribution of radioactivity and RSA in rats after the oral administration
of 1C-DEHP (1.41 IACi).a
Radioactivity, %
Organs 1 hr 2 hr 3 hr 6 hr 12 hr 24 hr
Brain 0.01 + 0.00 0.02 + 0.01 0.03 + 0.01 0.02 + 0.01 0.01 + 0.01 0.00
(0.01) (0.025) (0.036) (0.018) (0.005) (0.0003)
Heart 0.04 + 0.01 0.06 + 0.04 0.14 ± 0.05 0.10 + 0.02 0.04 + 0.02 0.01 + 0.00
(0.096) (0.14) (0.19) (0.27) (0.11) (0.03)
Lung 0.05 + 0.02 0.17 + 0.07 0.21 + 0.09 0.13 + 0.01 0.07 + 0.06 0.01 ± 0.01
(0.10) (0.32) (0.28) (0.23) (0.13) (0.02)
Liver 1.52 + 0.26 1.70 + 0.65 2.75 + 0.41 2.62 + 0.12 1.48 + 0.39 0.74 + 0.13
(0.43) (0.44) (0.69) (0.66) (0.36) (0.18)
Spleen 0.06 + 0.02 0.06 + 0.03 0.17 + 0.12 0.06 + 0.02 0.03 + 0.01 0.00
(0.07) (0.12) (0.24) (0.13) (0.03) (0.006)
Kidney 0.36 ± 0.14 0.34 ± 0.04 0.44 ± 0.21 0.51 + 0.14 0.23 ± 0.07 0.09 + 0.03
(0.42) (0.36) (0.48) (0.61) (0.32) (0.09)
Stomach 32.15 + 14.14 15.84 + 8.45 7.97 + 5.17 3.83 ± 1.09 1.00 + 0.58 0.20 ± 0.22
(33.1) (17.3) (8.08) (5.28) (1.39) (0.29)
Intestine 13.3b 35.62 ± 29.88 51.06 + 20.78 26.94 + 6.02 39.66 + 13.70 34.57b
(3.68b) (5.50) (6.54) (3.57) (5.70) (6.87b)
Testicle 0.03 ± 0.01 0.05 + 0.01 0.13 + 0.04 0.11 + 0.05 0.04 ± 0.02 0.01 + 0.00
(0.02) (0.05) (0.09) (0.09) (0.03) (0.006)
Blood 0.49 ± 0.30 0.54 ± 0.41 0.74 + 0.34 0.88 + 0.39 0.44 + 0.27 0.23 ± 0.16
(0.06) (0.07) (0.10) (0.11) (0.06) (0.03)
Muscle 3.16 + 1.39 4.15 + 2.53 4.86 + 1.93 4.37 + 1.61 1.46 ± 0.71 0.32 + 0.14
(0.08) (0.10) (0.12) (0.11) (0.04) (0.008)
Adipose 5.93 + 1.24 1.40 + 0.62 1.18 + 0.23 1.33 + 0.48 1.72 + 0.36 0.27 ± 0.09
(0.42) (0.10) (0.08) (0.11) (0.05) (0.02)
a Values are means + S.D., numbers in parentheses indicate RSA. Data of Tanaka et al. (20).
b One sample only.
hemoglobin, blood specific gravity, serium pro-
tein, serum calcium and clotting time were ex-
amined. After administration of 50 and 100
mg/kg of DEHP twice weekly, these param-
eters did not show significant deviation from
those observed in the control during a 3-month
period. The results obtained on blood coagula-
tion are shown in Table 4. Also Nakaura et al.
(18, 19) examined the changes in these blood
parameters for 3-6 months after an implanta-
tion of plastics for medical purposes into aortic
arch of rabbits and allowed the blood to freely
flow over the samples. The samples used were
PVC, Teflon, polyacetal, and Hydron. Again,
abnormal changes were not observed. Polycar-
bonate, polypropylene, and polyethylene bottles
were cut into pieces and extracted with saline
and 5% alcohol-saline solution. Using extracts
of these materials, acute toxicity tests with
mice, local irritation tests, and pyrogen tests
with rabbits showed negative results. Implan-
tation of these resins into dorsal
rabbits also revealed the lack of
effects.
muscles of
local toxic
Absorption, Distribution, and Metabolism
Tanaka et al. (20) administered 14C-DEHP
orally to rats and examined the absorption, dis-
tribution, metabolism, and excretion. About
40-50% was recovered after 7 days in the feces
and 30-35% in the urine. High accumulation
and slow decrease in radioactivity was found
in the liver and intestine after a single intra-
venous dose of 1.03 uCi of 14C-DEHP as shown
in Table 5. A delayed excretion of DEHP was
observed in particular in the adipose tissue
after oral administration of 1.41 fACi (Table
6). Orally ingested DEHP was excreted un-
changed in the feces, and urinary metabolites
such as monoethylhexyl phthalate and phthalic
acid were found.
Environmental Health Perspectives 208Table 7. Test methods on migration of phthalate esters and other substances into foods from containers or packages.
Temperature, Time, Limit of migration,
Case Extract solvent °C min Quantity ppm
I n-Heptane 60 30 2 ml/cm surface < 150
area
II 20% Ethanol 60 30 2 ml/cm surface < 30
III 4% Acetic acid 60 30 2 ml/cm surface < 30
Administrative Action on Phthalate Esters
The Ministry of Health and Welfare has es-
tablished the regulation on the migration of
phthalate esters and other substances from the
PVC container or packages for foodstuff, in
1973. This regulation demands limitation of
such migration from the PVC containers or
packaging material into the contents under the
certain levels. As shown in Table 7, this regu-
lation contains the examinations on three cases
for contents: case I for fats, oils and fatty
foodstuffs; case II for liquors, wines and alco-
holic beverages, and case III for other than the
above-mentioned foodstuffs.
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